Disclaimer: Content provided by Qwizzeria.
Matter-of-Fact of the week #22:
![Matter-of-Fact of the week #22:](https://i0.wp.com/namasteswitzerland.ch/wp-content/uploads/2017/10/novartis-logo.png?resize=725%2C453&ssl=1)
Recently, Novartis got an approval by the US FDA for a living drug to cure cancer. It is tailor-made to each patient, unlike conventional treatment. The drug therapy costs $475,000.